| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 12.4 | 13.1 | 14.0 |
| Other income | 0.7 | 1.2 | 1.2 |
| Total income | 13.1 | 14.3 | 15.2 |
| Profit before exceptional items & tax | 0.9 | 1.9 | 1.3 |
| Exceptional items | 0.4 | 0.0 | 0.0 |
| Profit before tax | 0.5 | 1.9 | 1.3 |
| Net profit | 0.1 | 1.4 | 0.9 |
| Operating margin | 3.8% | 13.3% | 8.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -88.90% |
|---|---|
| Net profit, quarter on quarter | -92.90% |
| Revenue, year on year | -11.40% |
Source
Read the filing ↗
NSE results filing, NSE: NIDAN. Figures extracted from the filing.
Nidan Laboratories And Healthcare Ltd: key numbers
- Share price
- ₹13.30
- Market cap
- ₹18.49 Cr
- Revenue (annual)
- ₹25.54 Cr
- Net profit (annual)
- ₹1.51 Cr
- P/E (TTM)
- 12.3×Sector 57.8×
- Promoter holding
- 57.04%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nidan Laboratories And Healthcare Ltd
All →
13:13 IST
NSE
Annual General Meeting
Nidan Laboratories And Healthcare Annual General Meeting
Nidan Laboratories and Healthcare Limited will hold its 26th Annual General Meeting on September 28, 2026. The company has submitted its Annual Report for FY 2025-26.